Xyla Stock

Xyla is a biomedical text-reading technology, aiming to organize and unlock the vast reservoir of published medical knowledge for improved research and patient care. Through its advancements in biomedical natural language processing, artificial intelligence, and machine learning, its technology analyzes vast swathes of medical text, extracting key entities and relationships.

Management Team

Daniel Nadler Founder and CEO

Notable Investors

Funding Information